期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖尿病患者药物洗脱支架植入术后冠脉再狭窄的因素分析 被引量：3

暂未订购
导出
摘要 目的分析影响糖尿病患者支架植入术后冠脉内再狭窄的因素。方法回顾性分析75例植入雷帕霉素洗脱支架的糖尿病患者,根据术后6个月造影结果,分析冠脉内再狭窄的预测因素。结果 1 9例患者（2 5.3%）出现冠脉内再狭窄,5 6例患者（74.7%）未出现冠脉内再狭窄。多因素回归分析显示,可以预测糖尿病患者冠脉内再狭窄的因素有：当前吸烟（OR=1.931,95%CI=1.01-4.85,P=0.031）,C反应蛋白浓度（OR=1.05,95%CI=1.02-1.08,P=0.041）,支架长度（OR=1.07,95%CI=1.03-1.21,P=0.040）,术前参考血管直径（OR=0.55,95%CI=0.13-0.95,P=0.041）,术后最小管腔直径（OR=0.445,95%CI=0.059-0.81,P=0.037）。结论较小基础管腔直径、术后较小管腔直径、较长支架长度、当前吸烟及高C反应蛋白浓度是糖尿病患者植入药物洗脱支架后再狭窄的重要预测因素。
作者 罗兵 贺立群 周军
机构地区 湖北省武汉市中西医结合医院 武汉市第一医院
出处 《中西医结合心脑血管病杂志》 2011年第7期778-779,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 糖尿病 药物洗脱支架 再狭窄 预测因素
分类号 R541.4 [医药卫生—心血管疾病] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献9

  • 1Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men withcoronary heart disease[J].Heart,2004,90:1398 - 403.
  • 2Kastrati A,Schomig A,Elezi S,et al. Predictive factors of resteno- sis after coronary stent placement[J]~. J Am Coll Cardiol, 1997,30: 1428 - 1436.
  • 3Komowski R,Mintz GS,Kent KM,et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia:A serial intravascular ultrasound study [J]. Circula- tion, 1997,95:1366 - 1369.
  • 4Peter M, Neeraj P, Sanh B, et al. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus[J] Am Heart J,2003,145:1013 - 1021.
  • 5Sousa JE,Costa MA,Sousa AG,et al. Two- year angiographie and intravascular ultrasound follow- up after implantation of sirolimus- eluting stents in human coronary arteries[J]. Circulation, 2003,107 (3) :381 - 383.
  • 6Beckman JA, Creager MA, Libby P. Diabetes and atheroselerosis; Epidemiology, pathophysiology, and management [ J ]. JAMA 2002,287 ..2570 - 2581.
  • 7Yusuf S,Zhao F,Mehta SR,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation[J]. N Engl J Meal,2001,345 ~494- 502.
  • 8Nishikawa H, Miura S, Shimomura H, et al. Combined treatment with statin and angiotensin - receptor blocker after stenting as a useful strategy for prevention of coronary restenosis[J]. J CardiQ1, 2005,45(3) :107 - 113.
  • 9Guneri S,Baris N, Aytekin D, et al. The relationship between an- giotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis : The role of angiotensin converting en- zyme inhibitors in stent restenosis in patients with diabetes melli- tus[J]. Int Heart J,2005,46(5) :889 - 897.

同被引文献32

  • 1谢锦桃,刘军,周盛鹏,朱素君,冷爱文.美国糖尿病协会2009糖尿病诊疗指南解读[J].中国全科医学,2009,12(14):1255-1257. 被引量：83
  • 2刘学波,王克强,葛均波.细胞迁移机制在冠状动脉支架再狭窄作用的研究进展[J].心血管病学进展,2004,25(6):436-439. 被引量：8
  • 3Lee SW,Park SW,Kim YH,et al.A randomized compari- son of sirolimus-versus Paclitaxel-eluting stent implanta- tion in patients with diabetes mellitus[J].J Am Coll Cardi- ol, 2005,52 (9) : 727-733.
  • 4Mahmud E,Bromberg-Marin G,Palakodeti V,et al.Clinical efficacy of drug-eluting stents in diabetic patients:a Ma- ta-analysis[J].J Am Coll Cardiol,2008,51 (25):2385-2595.
  • 5Tomai F,Reimers B,De Luca L,et al.Head-to-head compar- ison of sirolimus-and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions.A prospective,randomized,multicenter study[J].Diabetes Care, 2008,31(1) : 15-19.
  • 6Yavuz F, Ozer O, Ercan S, et al. Relationship between coronary in- stent restenosis and plasma urotensin I[ level [ J ]. Minerva Cardioangiol, 2014, 62 (3): 297-303.
  • 7Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions [ J]. Eur Heart J, 2004, 25 (19): 1679 -1687.
  • 8Kang SJ, Cho YR, Park GM, et al. Predictors for functionally significant in - stent restenosis : an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging [ J ]. JACC Cardiovasc Imaging, 2013, 6 (11) : 1183 -1190.
  • 9Varga - Szabo D, Braun A, Nieswandt B. STIM and Orai in platelet function [J]. Cell Calcium, 2011, 50 (3): 270-278.
  • 10Esteghamati A, Arefzadeh A, Zandieh A, et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric type 1 diabetic and control subjects [ J ]. J Endocrinol Invest, 2013, 36 (7): 474-477.

二级引证文献11

中西医结合心脑血管病杂志
2011年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部